The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance | NEJM
Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study - The Lancet Haematology
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Monoclonal gammopathy of renal significance: Early diagnosis is key | Nefrología
IJMS | Free Full-Text | Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma | HTML
Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement | Blood Cancer Journal
Prevalence of Monoclonal Gammopathy of Undetermined Significance | NEJM
Multiple Myeloma: Diagnosis and Treatment | AAFP
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management - Maciocia - 2017 - Hematological Oncology - Wiley Online Library
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS) | Blood Cancer Journal
Monoclonal gammopathy of undetermined significance - Kyle - 2006 - British Journal of Haematology - Wiley Online Library
Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis | SpringerLink
Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma - ScienceDirect
Minimal Residual Disease Negativity Does Not Overcome Poor Prognosis in High-Risk Multiple Myeloma: A Single-Center Retrospective Study - Clinical Lymphoma, Myeloma and Leukemia
IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration | SpringerLink
Monoclonal gammopathy of undetermined significance - Wikipedia
Cutaneous manifestations of monoclonal gammopathy | Blood Cancer Journal
Absolute Risk of Progression of MGUS to Myeloma or Related Disorders... | Download Table
Renal Manifestations of Plasma Cell Disorders - American Journal of Kidney Diseases
Neuropathy associated with IgA monoclonal Gammopathy. A harbinger of AL amyloidosis - Journal of the Neurological Sciences
